HTA and market access

Showing 9 of 0 results

• Flatiron Health triples global oncology research network, unlocking multinational evidence generation
  • Real-world evidence
  • Flatiron stories
  • Press releases
  • HTA and market access
• Crossing borders: the need for empirical evidence of real-world evidence transportability in oncology

  Journal of Comparative Effectiveness Research

  • Comparative effectiveness
  • HTA and market access
• Characterisation of oncology EHR-derived real-world data in the UK, Germany, and Japan

  ESMO Real-World Data and Digital Oncology

  • Real-world evidence
  • Publication summary
  • Publications
  • Data science
  • Methodology
  • HTA and market access
• Unicancer and Flatiron Health partner to accelerate regulatory-grade evidence generation from international Real-World Data
  • Press releases
  • HTA and market access
• Evaluating transportability of overall survival estimates from US to UK populations receiving first-line treatment for advanced non-small cell lung cancer: a retrospective cohort study

  BMJ Open

  • Publication summary
  • Publications
  • Non-small cell lung cancer
  • HTA and market access
• Unlocking the power of real-world data across the globe: Recent research accomplishments from Flatiron FORUM and multinational data
  • Real-world evidence
  • HTA and market access
• Filling critical evidence generation gaps with global oncology real-world data
  • Real-world evidence
  • Video
  • HTA and market access
• Assessing real-world data from electronic health records for health technology assessment: The SUITABILITY checklist: a good practices report of an ISPOR task force

  Value in Health

  • Publication summary
  • Publications
  • Data science
  • Methodology
  • Regulatory
  • HTA and market access
  • AP - Blythe Adamson, MPH, PhD
• Transporting comparative effectiveness evidence between countries: considerations for health technology assessment

  Pharmacoeconomics

  • Real-world evidence
  • Video
  • Publication summary
  • Publications
  • HTA and market access